Literature DB >> 16840539

FOXL2 in the pituitary: molecular, genetic, and developmental analysis.

Buffy S Ellsworth1, Noboru Egashira, Jodi L Haller, Darcy L Butts, Julie Cocquet, Colin M Clay, Robert Y Osamura, Sally A Camper.   

Abstract

FOXL2 is a forkhead transcription factor expressed in the eye, ovary, and pituitary gland. Loss of function mutations in humans and mice confirm a functional role for FOXL2 in the eye and ovary, but its role in the pituitary is not yet defined. We report that FOXL2 colocalizes with the glycoprotein hormone alpha-subunit (alphaGSU) in quiescent cells of the mouse pituitary from embryonic d 11.5 through adulthood. FOXL2 is expressed in essentially all gonadotropes and thyrotropes and a small fraction of prolactin-containing cells during pregnancy, but not somatotropes or corticotropes. The coincident expression patterns of FOXL2 and alphaGSU suggested that the alphaGSU gene (Cga) is a downstream target of FOXL2. We demonstrate that FOXL2 regulates mouse Cga transcription in gonadotrope-derived (alphaT3-1, LbetaT2), thyrotrope-derived (alphaTSH) and heterologous (CV-1) cells in a context-dependent manner. In addition, a FOXL2-VP16 fusion protein is sufficient to stimulate ectopic Cga expression in transgenic animals. Normal FOXL2 expression requires the transcription factors Lhx3 and Lhx4 but not of Prop1. Thus, FOXL2 expression is affected by mutations in early pituitary developmental regulatory genes, and its expression precedes that of genes necessary for gonadotrope-specific development such as Egr1 and Sf1 (Nr5a1). These data place FOXL2 in the hierarchy of pituitary developmental control and suggest a role in regulation of Cga gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840539     DOI: 10.1210/me.2005-0303

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  51 in total

1.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Authors:  Frank Batista; Daniel Vaiman; Jean Dausset; Marc Fellous; Reiner A Veitia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

Review 2.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

Review 3.  Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.

Authors:  S W Davis; F Castinetti; L R Carvalho; B S Ellsworth; M A Potok; R H Lyons; M L Brinkmeier; L T Raetzman; P Carninci; A H Mortensen; Y Hayashizaki; I J P Arnhold; B B Mendonça; T Brue; S A Camper
Journal:  Mol Cell Endocrinol       Date:  2009-12-16       Impact factor: 4.102

4.  The forkhead transcription factor Foxl2 is sumoylated in both human and mouse: sumoylation affects its stability, localization, and activity.

Authors:  Mara Marongiu; Manila Deiana; Alessandra Meloni; Loredana Marcia; Alessandro Puddu; Antonio Cao; David Schlessinger; Laura Crisponi
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

5.  Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.

Authors:  S Nuovo; M Passeri; E Di Benedetto; M Calanchini; I Meldolesi; M C Di Giacomo; D Petruzzi; M R Piemontese; L Zelante; F Sangiuolo; G Novelli; A Fabbri; F Brancati
Journal:  J Endocrinol Invest       Date:  2015-06-23       Impact factor: 4.256

Review 6.  Fox tales: regulation of gonadotropin gene expression by forkhead transcription factors.

Authors:  Varykina G Thackray
Journal:  Mol Cell Endocrinol       Date:  2013-10-04       Impact factor: 4.102

7.  Essential but differential role of FOXL2wt and FOXL2C134W in GDF-9 stimulation of follistatin transcription in co-operation with Smad3 in the human granulosa cell line COV434.

Authors:  David Nonis; Kirsten J McTavish; Shunichi Shimasaki
Journal:  Mol Cell Endocrinol       Date:  2013-03-21       Impact factor: 4.102

8.  Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution.

Authors:  Robert Y Osamura; Noboru Egashira; Hanako Kajiya; Mao Takei; Maya Tobita; Takashi Miyakoshi; Chie Inomoto; Susumu Takekoshi; Akira Teramoto
Journal:  Acta Histochem Cytochem       Date:  2009-08-11       Impact factor: 1.938

9.  WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth.

Authors:  Mary Anne Potok; Kelly B Cha; Andrea Hunt; Michelle L Brinkmeier; Michael Leitges; Andreas Kispert; Sally A Camper
Journal:  Dev Dyn       Date:  2008-04       Impact factor: 3.780

10.  Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

Authors:  Bérénice A Benayoun; Sandrine Caburet; Aurélie Dipietromaria; Adrien Georges; Barbara D'Haene; P J Eswari Pandaranayaka; David L'Hôte; Anne-Laure Todeschini; Sankaran Krishnaswamy; Marc Fellous; Elfride De Baere; Reiner A Veitia
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.